Prognostic impacts of soluble form of basigin in patients with chronic heart failure -from a prospective large clinical trial with 1,147 patients-

Back

ESC Premium Access

Prognostic impacts of soluble form of basigin in patients with chronic heart failure -from a prospective large clinical trial with 1,147 patients-

Session: Exploring biomarkers in heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor K. Satoh (Sendai, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Associate Professor Kimio Satoh

Tohoku University, Sendai (Japan)

0 follower

9 more presentations in this session

Mid regional atrial natriuretic peptide is an independent predictor of peak pulmonary capillary wedge pressure in patients with heart failure with preserved ejection fraction

Speaker: Doctor S. Nanayakkara (Melbourne, AU)

Association of NGAL and AHEAD score for two-year prognosis in chronic heart failure patients (FAR NHL registry)

Speaker: Doctor K. Labr (Brno, CZ)

Machine learning facilitates selecting a group of metabolites non-inferior to BNP for the diagnosis of chronic heart failure

Speaker: Doctor M. Marcinkiewicz-Siemion (Bialystok, PL)

Optimizing patient selection in heart failure trials: the role of NT-proBNP

Speaker: Doctor G. Savarese (Stockholm, SE)

Diagnostic value of MRproANP in detecting non-acute heart failure in primary care

Speaker: Doctor A. Gohar (Derby, GB)

Access the full session

Exploring biomarkers in heart failure

Speakers: Associate Professor K. Satoh, Doctor S. Nanayakkara, Doctor K. Labr, Doctor M. Marcinkiewicz-Siemion, Doctor G. Savarese...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources